Cedars Healthcare Center Medicare and Medicaid Location: 1242 Cedars Ct, Charlottesville, Virginia 22903 Ratings: Phone: (434) 296-5611 |
Charlottesville Health & Rehabilitation Center Medicare and Medicaid Location: 505 West Rio Road, Charlottesville, Virginia 22901 Ratings: Phone: (434) 978-7015 |
Westminster Canterbury Blue Ri Medicare and Medicaid Location: 250 Pantops Mountain Rd, Charlottesville, Virginia 22911 Ratings: Phone: (434) 972-3100 |
Colonnades Health Care Center Medicare and Medicaid Location: 100 Colonnades Hill Drive, Charlottesville, Virginia 22901 Ratings: Phone: (804) 963-4198 |
Monroe Health & Rehab Center Medicare and Medicaid Location: 1150 Northwest Drive, Charlottesville, Virginia 22901 Ratings: Phone: (434) 973-7933 |
The Laurels Of Charlottesville Medicare and Medicaid Location: 490 Hillsdale Drive, Charlottesville, Virginia 22901 Ratings: Phone: (434) 951-4200 |
Albemarle Health And Rehabilitation Center Medicare and Medicaid Location: 1540 Founders Place, Charlottesville, Virginia 22902 Ratings: Phone: (434) 422-4800 |
Our Lady Of Peace Inc Medicaid Location: 751 Hillsdale Drive, Charlottesville, Virginia 22901 Ratings: Phone: (434) 973-1155 |
News Archive
Today the American College of Surgeons announced the launch of a new initiative aimed at stimulating more young surgeons (defined as under the age of 45) to become involved in the organization and increase membership.
A new particle accelerator will further enhance the research landscape at Johannes Gutenberg University Mainz. It is to be employed to conduct research into potential applications of medical relevance.
The 5th ESU Master class on medical treatment for urological cancer is organised by the European School of Urology (ESU) on 25-27 June 2010 at the Barcel- Hotel Sants in Barcelona, Spain.
The University of Maryland Biotechnology Institute (UMBI) today announced the exclusive licensing of a fully human antibody technology platform to Prolias, a biotechnology company working to discover and develop novel therapeutic proteins and antibodies for treatment of disease.
Hadasit Bio-Holdings a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced that the recruitment of 13 patients for the Enlivex Phase I/II clinical trial has been completed.
› Verified 8 days ago